Tag Archives: NASDAQ:MRNS

Robert W. Baird Remains a Buy on Marinus (MRNS)

Robert W. Baird analyst Brian Skorney maintained a Buy rating on Marinus (MRNS – Research Report) on May 17 and set a price target of $32.00. The company’s shares closed last Wednesday at $14.77. According to TipRanks.com, Skorney is a

Analysts Are Bullish on Top Healthcare Stocks: Marinus (MRNS), Moderna (MRNA)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Marinus (MRNS – Research Report) and Moderna (MRNA – Research Report) with bullish sentiments. Marinus (MRNS) Ladenburg Thalmann & Co. analyst Michael

Oppenheimer Remains a Buy on Marinus (MRNS)

The company’s shares closed last Tuesday at $12.56. According to TipRanks.com, Olson is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -3.8% and a 41.5% success rate. Olson covers the Healthcare sector,

Marinus (MRNS) Gets a Buy Rating from H.C. Wainwright

H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Marinus (MRNS – Research Report) today and set a price target of $9.00. The company’s shares closed last Monday at $2.11. According to TipRanks.com, Tsao is a 5-star analyst with

Marinus (MRNS) Receives a Buy from Oppenheimer

In a report released yesterday, Jay Olson from Oppenheimer maintained a Buy rating on Marinus (MRNS – Research Report), with a price target of $6.00. The company’s shares closed last Friday at $1.84. According to TipRanks.com, Olson has currently 0

Oppenheimer Assigns a Buy Rating on Marinus (MRNS)

In a report released today, Jay Olson from Oppenheimer assigned a Buy rating to Marinus (MRNS – Research Report), with a price target of $6.00. The company’s shares closed last Friday at $1.80. According to TipRanks.com, Olson is ranked 0